Abstract:The aim of this study was to investigate the plasma proteome in individuals with intracranial aneurysms (IAs) and identify biomarkers associated with the formation and rupture of IAs. Proteomic profiles ( N = 1069 proteins) were assayed in plasma ( N = 120) collected from patients with ruptured and unruptured intracranial aneurysms (RIA and UIA), traumatic subarachnoid hemorrhage (tSAH), and healthy controls (HC) using tandem mass tag (TMT) labeling quantitative proteomics analysis. Gene ontology (GO) and pathway analysis revealed that these relevant proteins were involved in immune response and extracellular matrix organization pathways. Seven candidate biomarkers were verified by ELISA in a completely separate cohort for validation ( N = 90). Among them, FN1, PON1, and SERPINA1 can be utilized as diagnosis biomarkers of IA, with a combined area under the ROC curve of 0.891. The sensitivity was 93.33%, specificity was 75.86%, and accuracy was 87.64%. PFN1, ApoA-1, and SERPINA1 can serve as independent risk factors for predicting aneurysm rupture. The combined prediction of aneurysm rupture yielded an area under the ROC curve of 0.954 with a sensitivity of 96.15%, specificity of 81.48%, and accuracy of 88.68%. This prediction model was more effective than PHASES score. In conclusion, high-throughput proteomics analysis with population validation was performed to assess blood-based protein expression characteristics. This revealed the potential mechanism of IA formation and rupture, facilitating the discovery of biomarkers. Significance Although the annual rupture rate of small unruptured aneurysms is believed to be minimal, studies have indicated that ruptured aneurysms typically have an average size of 6.28 mm, with 71.8% of them being <7 mm in diameter. Hence, evaluating the possibility of rupture in UIA and making a choice between aggressive treatment and conservative observation emerges as a significant challenge in the management of UIA. No biomarker or scoring system has been able to satisfactorily address this issue to date. It would be significant to develop biomarkers that could be used for early diagnosis of IA as well as for prediction of IA rupture. After TMT proteomics analysis and ELISA validation in independent populations, we found that FN1, PON1, and SERPINA1 can be utilized as diagnostic biomarkers for IA, and PFN1, ApoA-1, and SERPINA1 can serve as independent risk factors for predicting aneurysm rupture. Especially, when combined with ApoA-1, SERPINA1, and PFN1 for predicting IA rupture, the area under the curve (AUC) was 0.954 with a sensitivity of 96.15%, specificity of 81.48%, and accuracy of 88.68%. This prediction model was more effective than PHASES score.

Featured Protein Analysis of Intracranial Aneurysms with Label-Free Quantitative Mass Spectrometry and Bioinformatics

Bioinformatics analysis of gene expression profile data to screen key genes involved in intracranial aneurysms

Abstract WP346: A Cost-effective and Reproducible Mouse Model of Intracranial Aneurysm: Renal Hypertension and Local Hemodynamic Change Combined with Elastase Infusion

Comparative Bioinformatics Analysis Between Proteomes of Rabbit Aneurysm Model and Human Intracranial Aneurysm with Label‐free Quantitative Proteomics

Integrated Transcriptional Profiling Analysis and Immune-Related Risk Model Construction for Intracranial Aneurysm Rupture

Circulating Proteomic Panels for Risk Stratification of Intracranial Aneurysm and Its Rupture

Integrative bioinformatics analysis of miRNA and mRNA expression profiles and identification of associated miRNA-mRNA network in intracranial aneurysms

Plasma proteomics analysis reveals potential biomarkers for intracranial aneurysm formation and rupture

Integrated metagenomic and metabolomic analysis reveals distinctive stage-specific gut-microbiome-derived metabolites in intracranial aneurysms

Search for Biomarkers of Intracranial Aneurysms: A Systematic Review

Global Gene Expression Patterns and Somatic Mutations in Sporadic Intracranial Aneurysms

Profiling of immune infiltration landscape of ruptured intracranial aneurysm

Identifying and validating key genes mediating intracranial aneurysm rupture using weighted correlation network analysis and exploration of personalized treatment

Identification of differentially expressed autophagy-related genes in cases of intracranial aneurysm: Bioinformatics analysis

Identifying novel risk genes in intracranial aneurysm by integrating human proteomes and genetics

Exploration of the shared gene signatures and molecular mechanisms between Alzheimer's disease and intracranial aneurysm

Untargeted metabolomics to detect and identify plasma metabolic signatures associated with intracranial aneurysm and its rupture

Biomarker study of symptomatic intracranial atherosclerotic stenosis in patients with acute ischemic stroke

Bioinformatics analysis reveals potential biomarkers associated with the occurrence of intracranial aneurysms

Exploring the Molecular Pathways of Intracranial Aneurysm Formation in Autosomal Dominant Polycystic Kidney Disease Using Proteomic Analysis

Identification and validation of key genes mediating intracranial aneurysm rupture by weighted correlation network analysis